Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Study of Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)

PRINcIPAL RESEARCHERS

Rory Collins (University of Oxford)

Jane Armitage (University of Oxford)

Data ownership

Clinical Trial Service Unit and Epidemiological Unit (CTSU), University of Oxford

Funding

Merck; CTSU also received funding from the UK Medical Research Council and the British Heart Foundation.

Publications

Website

 

Other trial-related materials